Project Grant HT94252410261
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$815K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Albany, NY 12208, USA
Similar Awards
Albany Medical College received a $733,500 Project Grant award from the Defense Health Agency dated June 1, 2023 through May 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). Through this award, Albany Medical College will conduct research investigating medical solutions for the battlefield by harnessing RVE1 to treat bone marrow failure. The Military Medical Research and Development program aims to transform military and public health through...
This federal Project Grant award from the Defense Health Agency supports Albany Medical College's research project titled "TARGETING DENDRITIC CELLS TO PREVENT HBV CHRONIC DISEASE". The $2,464,874 award, which runs from July 1, 2024 to June 30, 2028, is funded through the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The project aims to advance medical knowledge and improve healthcare for military service members, veterans, and their...
This $822,501 Project Grant was awarded on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant is funding research by The Trustees of Columbia University in the City of New York (Health Sciences Division) to investigate "Restoring GABAergic Inhibition as a Potential Therapy for TSC-Associated Neurocognitive Impairment". The research aims to explore innovative approaches to preventing, diagnosing,...
The Department of the Army Medical Command awarded a $879,721 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Trustees of Columbia University in the City of New York. The grant, with a performance period from April 1, 2025 to March 31, 2027, will fund the evaluation of small molecule ferroptosis inhibitors in a GPX4 amyotrophic lateral sclerosis (ALS) model. This research aims to transform healthcare for military service members and the public by...
The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $312,610.00 to Weill Medical College of Cornell University to conduct research on the "Role of Functional Factors in AR Reprogramming and Progression of Prostate Cancer." The award, effective from September 30, 2024 to September 29, 2026, supports advanced biomedical research initiatives focused on transforming...
The Department of the Army Medical Command, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,229,872 project grant to Baylor College of Medicine to fund research on the clinical and genetic architecture of autism spectrum disorder among individuals with tuberous sclerosis complex. The 3-year grant, commencing on July 1, 2025, and concluding on June 30, 2028, will support advanced biomedical research initiatives focused on transforming healthcare for...
The Department of the Army Medical Command awarded a $462,000.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Albert Einstein College of Medicine in Bronx, NY. The grant, with a performance period from January 1, 2025 to December 31, 2026, supports advanced biomedical research focused on the "Proteomics of Vascular Wall Aging." As a prominent research institution, the Albert Einstein College of Medicine will leverage its expertise in...
This federal Project Grant award of $802,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports preclinical gene therapy studies in a mouse model of TSC2 at Baylor College of Medicine in Houston, TX. The award, effective May 1, 2025 through April 30, 2028, will fund advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The program typically supports a wide range of...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...